Beta<sub>2</sub>‐Adrenergic Stimulation Induces Resistance Training‐Like Adaptations in Human Skeletal Muscle: Potential Role of <scp>KLHL41</scp>
Skeletal muscle mass plays a pivotal role in metabolic function, but conditions such as bed rest or injury often render resistance training impractical. The beta<sub>2</sub>-adrenergic receptor has been highlighted as a potential target to promote muscle hypertrophy and treat atrophic conditions. Here, we investigate the proteomic changes associated with beta<sub>2</sub>-adrenergic-mediated muscle hypertrophy, using resistance training as a hypertrophic comparator. We utilize MS-based proteomics to map skeletal muscle proteome remodeling in response to beta<sub>2</sub>-adrenergic stimulation or resistance training as well as cell model validation. We report that beta<sub>2</sub>-adrenergic stimulation mimics multiple features of resistance training in proteome-wide remodeling, comprising systematic upregulation of ribosomal subunits and concomitant downregulation of mitochondrial proteins. Approximately 20% of proteins were regulated in both conditions, comprising proteins involved in steroid metabolism (AKR1C1, AKR1C2, AKRC1C3), protein-folding (SERPINB1), and extracellular matrix organization (COL1A1, COL1A2). Among overall most significantly upregulated proteins were kelch-like family members (KLHL) 40 and 41. In follow-up experiments, we identify KLHL41 as having novel implications for beta<sub>2</sub>-adrenergic-mediated muscle hypertrophy. Treating C2C12 cells with beta<sub>2</sub>-agonist for 96 h increased myotube diameter by 48% (p < 0.001). This anabolic effect was abolished by prior knockdown of KLHL41. Using siRNA, KLHL41 abundance was decreased by 60%, and the anabolic response to beta<sub>2</sub>-agonist was diminished (+ 15%, i.e., greater in the presence of KLHL41, knock-down × treatment: p = 0.004). In conclusion, protein-wide remodeling induced by beta<sub>2</sub>-adrenergic stimulation mimics multiple features of resistance training, and thus the beta<sub>2</sub>-adrenergic receptor may be a target with therapeutic potential in the treatment of muscle wasting conditions without imposing mechanical load.
Authors
- Søren Jessen (ORCID: https://orcid.org/0000-0002-7461-1264)
- Glenn A. Jacobson (ORCID: https://orcid.org/0000-0002-3409-8769)
- Roger Moreno‐Justicia (ORCID: https://orcid.org/0000-0002-8587-4772)
- Richard Wilson (ORCID: https://orcid.org/0000-0003-0152-4394)
- Andrea Di Credico (ORCID: https://orcid.org/0000-0002-8388-9305)
- Júlia Prats Quesada (ORCID: https://orcid.org/0000-0003-2802-7291)
- Atul S. Deshmukh (ORCID: https://orcid.org/0000-0002-2278-1843)
- Morten Hostrup (ORCID: https://orcid.org/0000-0002-6201-2483)
- Jens Bangsbo (ORCID: https://orcid.org/0000-0003-1305-9274)
Institutions
- University of Copenhagen (DK)
- University of Tasmania (AU)
- Novo Nordisk Foundation (DK)
- University of Chieti-Pescara (IT)
Publication Details
- Journal
- Scandinavian Journal of Medicine and Science in Sports
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1111/sms.14736
- Citations
- 11
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.59
Funders
- Novo Nordisk Fonden